Home » interviews » Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics

  • November 24, 2025

Interviews

Only 4-5 I
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 I
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
View More

Appointments

Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics
Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics
Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence
Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence
Hester Biosciences appoints Ashish Desai as CFO
Hester Biosciences appoints Ashish Desai as CFO
View More

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
View More

Digitization

Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform
Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform
L&T Technology unveils next-gen AI digital twin for lung diagnostics
L&T Technology unveils next-gen AI digital twin for lung diagnostics
Roche expands Veeva partnership with global rollout of AI-driven Vault CRM
Roche expands Veeva partnership with global rollout of AI-driven Vault CRM
View More

Latest Stories

Lilly drug cuts risk of cancer progression, extends survival in advanced breast cancer trial

Glenmark Pharmaceuticals USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial single-dose vial

Suven Life Sciences achieved 100% patient enrolment in Phase-2b clinical trial of Ropanicant for MDO

Alembic receives USFDA final approval for Loteprednol Etabonate and Tobramycin Ophthalmic suspension

GSK’s experimental lung cancer drug gains FDA orphan drug status

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging